跳到正文
原文
Endpoints News 生物医药· Ryan Cross·· 2026-10-14AI 评分36

Arrowhead Pharma 靶向脑部 RNA 药物在早期研究中降低阿尔茨海默病蛋白 tau 水平

Arrowhead’s brain-targeting RNA drug lowers Alzheimer’s protein in early study

AI 导读

Arrowhead Pharmaceuticals 的一项早期研究表明,其皮下注射的遗传学药物似乎能进入脑部并降低 tau 蛋白水平。该 tau 蛋白是阿尔茨海默病的一个生物标志物。

正文

Ar­row­head Phar­ma­ceu­ti­cals has shown that a ge­net­ic med­i­cine ad­min­is­tered as a sub­cu­ta­neous in­jec­tion can seem­ing­ly trav­el in­to the brain and low­er lev­els of tau, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news